Tamoxifen Citrate
Product Images NDC 51862-642

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tamoxifen Citrate (NDC 51862-642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Commercial Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Tamoxifen 01)

Chemical Structure (Tamoxifen 01)
Chemical structure diagram showing the molecular formula of tamoxifen citrate, illustrating its aromatic rings and key functional groups.*
FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Principal Display Panel (10 mg Tablet Bottle Label)
Tamoxifen Citrate Tablets, USP label showing 10 mg (base) strength. The label includes the NDC 51862-642-60, package quantity of 60 tablets, and distribution by Mayne Pharma Commercial LLC, Greenville, NC. Storage instructions specify 20° to 25°C with avoidance of excessive heat. The product is marked Rx only and manufactured in Israel.*
FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

Principal Display Panel (20 mg Tablet Bottle Label)
Tamoxifen Citrate Tablets, USP 20 mg (base) label shows dispensing and storage instructions. It includes the NDC 51862-643-30, and indicates the product contains 20 mg tamoxifen equivalent to 30.4 mg tamoxifen citrate per tablet. The label instructs pharmacists to provide a medication guide and notes it is Rx Only, with 30 tablets per container distributed by Mayne Pharma Commercial LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.